Denali Therapeutics (D2NL34.SA) Q4 2024 Earnings

Nov 6Confirmed
Q4 2023
Q2 2024
Q3 2024
Q4 2024
-4.24
-3.95
-3.67
-3.38

Details

Expected EPS
-3.3768578376000002
Actual EPS
-3.575124
Surprise EPS
-0.2
Surprise Percent
-5.87%

Description

⁨Denali Therapeutics⁩ (⁦D2NL34.SA⁩) has reported earnings of ⁦-3.575124⁩ per share for ⁦Q4 2024⁩.

0 Comments

Share your thoughts